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Aim.Theaimofthisstudywastoseewhetherthebeneﬁtsofcrossedwireﬁxationoverskeletaltractioninthetreatmentofpediatric
supracondylar humerus fractures (SCHF) were mirrored in the children’s or their caregivers’ rating of the experience. Methods.A s
part of a study of the clinical outcome of SCHF, all the patients and the parents were asked to rate their experience of the treatment
on a visual analogue scale (VAS). Results.T h e r ew a sn od i ﬀerence in the patients’ or the parents’ experience between the treatment
groups. However there was a diﬀerence between the parents with children who experienced a neurovascular complication (mean
VAS 6.1) and those that did not (mean VAS 4.3, P = 0.03). The boys rated the experience as less negative (mean VAS 3.6) than the
girls (mean VAS 4.7, P = 0.02). Conclusion. In the long term, avoiding complications was more important to the parents than the
choice of treatment for SCHF in the children.
1.Introduction
Supracondylar humerus fractures (SCHFs) are the fractures
in childhood most associated with serious complications
[1–8]. Undisplaced fractures, Gartland type 1, are generally
treated with immobilization in a cast with good results
[6, 9, 10]. However, there has been a considerable danger of
serious complications with the treatment of displaced SCHF
inaplasterofParis(POP)castwithhyperﬂexion[8].Forthis
reason Dunlop used straight arm skin traction for these frac-
tures from the late nineteen twenties [11]. The introduction
of traction reduced the number of complications associated
with this fracture [12], and skeletal traction with a K-wire [9,
13]o ras c r e w[ 14] in the olecranon has later shown to pro-
vide better control of fracture reduction. From the nineteen
thirtiesandonward,severalpaperswerepublishedonK-wire
ﬁxation of SCHF [15–17], until this became the treatment
of choice for this fracture in children in most hospitals
in Europe and America during the nineteen eighties and
nineties. It was introduced to Haukeland University Hospital
(HUH) in 1992 by the senior author (L. B. Engesaeter). Prior
to this, overhead skeletal traction was used as the standard
treatment for SCHF at HUH. From 1992 until crossed wire
ﬁxation was ﬁrmly established as the treatment of choice in
1995, skeletal traction was still used by some surgeons on
call [18]. HUH is the tertiary referral centre for pediatric
orthopedics and trauma for Western Norway and serves a
population of approximately 900000. It is the only hospital
oﬀering treatment for displaced supracondylar humerus
fractures in a population of approximately 300000 in and
around the city of Bergen. The majority of undisplaced
fractures are treated at a separate institution.
Though there are obvious and well-proven beneﬁts of
wire ﬁxation over skeletal traction, such as a shorter hospital
stay [18], to our knowledge, no studies of patient and care-
giver satisfaction comparing diﬀerent treatments for SCHF
exist. The aim of this study was to investigate whether the
presumed beneﬁts of crossed wire ﬁxation over skeletal trac-
tion are mirrored in the children’s or their caregivers’ sub-
jective experience of the treatment at long-term followup.2 Advances in Orthopedics
2. Patientsand Methods
268 children were treated at the Haukeland University Hos-
pital for a pediatric distal humerus fracture from 01.01.1988
to 31.12.1998. On review of the case notes of all these pa-
tients, 181 consecutive patients with isolated supracondylar
humerus fracture were identiﬁed. These were invited for a
follow-up visit to the pediatric orthopedic outpatient clinic
at HUH. 141 of the 181 patients (78%) attended the clinic.
Two of these on closer examination turned out to be lateral
humerus condyle fractures and were excluded, leaving 139
patients for this study. The parents of all children gave their
informedconsenttothemselvesandtheirchildtakingpartin
this study. The epidemiological and clinical results have been
published in an earlier article [18].
The parents/caregivers and the children were all asked
to rate their experience of the fracture and its treatment on
a visual analogue scale (VAS) from 0 to 10 where 0 was “No
problem at all” and 10 was “A terrible experience.” The chil-
dren were examined with regards to elbow function, neuro-
vascular function, and deformity. The medical records of
all the patients were examined separately from the clinical
examination. We recorded the injured arm, the date and
time of injury, time of admittance, and time of surgery. Pre-
and postoperative vascular status, nerve function, infection,
and number of reoperations were also noted. VAS scores
were compared according to fracture classiﬁcation, four
diﬀerent treatment groups, the presence or absence of a
complication, the time from injury to surgery, and the time
from injury to followup.
2.1. Fracture Classiﬁcation. The fractures were classiﬁed ret-
rospectively at followup using Wilkins’ modiﬁed version of
Gartland’s classiﬁcation [6, 10].
2.2. Treatment Groups. The patients were divided into four
groups according to the treatment they received; POP cast
only (40 children), overhead skeletal traction (46 children),
closed reduction with percutaneous crossed wire ﬁxation (45
children), and open reduction with crossed wire ﬁxation (8
children) [18]. The undisplaced fractures were treated with
a plaster of Paris (POP) cast with the elbow ﬂexed at 90
degrees. Overhead skeletal traction was performed using a
winged Palmer olecranon screw. After a mean 11 days in
traction a POP, cast was applied and the Palmer screw was
removed, usually in general anesthesia (GA). Crossed wire
ﬁxation was done percutaneously and a cast applied in GA.
The pins were removed in the outpatient department after
fourweekswithonlyacetaminophenaspremedication.Eight
patients were treated with open reduction and crossed pin
ﬁxation because of failure to reduce the fracture by closed
means or due to vascular injury.
2.3. Complication Group. Seventeen (12%) of the 139 chil-
dren had an observed nerve injury at some point during
treatment or followup. 15 of these had Gartland type 3
fractures. No nerve injuries were recorded in patients with
Gartland type 2 fractures. In the plaster cast group, two
childrenwithfracturesclassiﬁedasGardentype1werefound
to have sensory loss in the distribution of the median and
radial nerve, respectively, at the followup. One child had a
cold, pale, and pulseless arm necessitating exploration and
repair of the brachial artery. Three other children had an
absent radial pulse that later normalized. All the 21 (15%)
childrenthatexperiencedacomplicationweredeﬁnedasone
group for the detailed analysis.
2.4. Statistics. The Student t-test was used to compare the
means of the continuous variables between the treatment
groups.AllP valuesweretwotailed,andthelevelofstatistical
signiﬁcance was set to 5% (P ≤ 0.05). The data was analyzed
using SPSSversion17.0(SPSSInc.,Chicago, IL60606, USA).
Power analysis was carried out using G∗Power 3.1.2 (Faul,
Erdfelder, Lang, and Buchner, 2006, 2009) [19]. It showed
that (given sample sizes of 45 patients, α = 0.05, and a power
of 80%) measurable eﬀect size would be approximately 0.6.
This would, in our material, be equivalent to approximately
ad i ﬀerence in VAS of 1.7.
3. Results
Atotalof104parentsand111childrenratedtheirexperience
on a predesigned VAS. The results with mean VAS for each
group,alongwiththenumberofcasesandthestandarderror
of the mean (SEM), are presented in Table 1. The mean time
frominjurytofollowupoverallwas7.1years(SEM0.27),5.2
years (SEM 0.36) for the crossed pin ﬁxation group, and 9.9
years (SEM 0.38) for the skeletal traction group (P<0.001).
In the skeletal traction group mean age at followup was 16.7
(SD 3.8) years. The mean age in the wire ﬁxation group was
11.8(SD3.0)yearsatfollowup.Parentsratedtheirexperience
of their child being treated for SCHF on average as 4.5 (SEM
0.27) on a VAS scale from 0 to 10. The children’s mean VAS
score was 4.1 (SEM 0.24, P = 0.22). There was no statistical
diﬀerenceinthechildren’sortheparents’VASscoresbetween
the POP, skeletal traction, or crossed wire ﬁxation groups.
Likewise, there was no statistical diﬀerence in VAS scores
according to the severity of the fracture (Gartland’s type),
time from injury to surgery more or less than eight hours
or time passed from injury to followup. However, there was
a signiﬁcant diﬀerence (P = 0.03, Figure 1)b e t w e e nam o r e
negative experience by the parents who had experienced a
neurovascular complication in their children at some time
during the treatment (mean VAS 6.1) and those parents who
did not (mean VAS 4.3). The same trend (P = 0.10) could be
observed in the equivalent groups of children. There was also
ad i ﬀerence (P = 0.02) in how the boys (mean VAS 3.6) and
the girls (mean VAS 4.7) perceived their experience, whereas
their parents did not diﬀerentiate between the girls (mean
VAS 4.5) and the boys (mean VAS 4.5).
4. Discussion
The VAS is a quick and easy method of rating a subjective
experience such as pain and anxiety and has been used
in similar studies both with children and adults [20, 21].Advances in Orthopedics 3
Table 1: Parents’ and children’s rating of experience of being treated for SCHF. VAS scale 0–10. 0 is no negative experience at all, 10 a very
negative experience.
Treatment
POP Skeletal traction Closed reduction and
crossed pin ﬁxation
Open reduction and
crossed pin ﬁxation
VAS (n)S E MV A S ( n)S E M V A S ( n)S E M V A S ( n)S E M
Parents 4.1 (32) 0.48 4.8 (24) 0.50 4.7 (42) 0.47 4.2 (6) 1.1
Children 3.4 (30) 0.43 4.4 (40) 0.37 4.4 (35) 0.46 3.5 (6) 1.4
Fracture dislocation
Gartland’s type 1 Gartland’s type 2 Gartland’s type 3
VAS (n)S E MV A S ( n)S E M VAS (n)S E M
Parents 4.3 (15) 0.75 4.2 (30) 0.46 4.6 (56) 0.38
Children 3.5 (17) 0.44 3.4 (24) 0.51 4.4 (66) 0.33
Time from injury to followup
Followup 0–4 years Followup 5–7 years Followup ≥ 8 years
VAS (n)S E MV A S ( n)S E M VAS (n)S E M
Parents 4.1 (42) 0.45 4.6 (35) 0.48 4.9 (26) 0.49
Children 3.7 (37) 0.42 4.4 (26) 0.52 4.1 (47) 0.36
Time from injury to surgery
< 8h o u r s ≥ 8h o u r s
VAS (n)S E M V A S ( n)S E M
Parents 4.3 (47) 0.39 3.4 (15) 0.62
Children 4.3 (45) 0.41 2.7 (12) 0.60
Gender
Girls Boys
VAS (n)S E M V A S ( n)S E M
Parents 4.5 (45) 0.38 4.5 (59) 0.38
Children 4.7∗ (46) 0.38 3.6∗ (65) 0.30
Experience of neurovascular complications
Complications No complications
VAS (n)S E M V A S ( n)S E M
Parents 6.1∗∗ (13) 0.67 4.3∗∗ (91) 0.29
Children 4.9∗∗∗ (18) 0.62 3.9∗∗∗ (93) 0.26
∗P = 0.02, ∗∗P = 0.03, ∗∗∗P = 0.10.
SEM = standard error of the mean.
The use of a single VAS score to rate patients’ and caregivers’
experience with a treatment may not give a complete picture
of this experience, but in our opinion gives an idea of how
positive or negative that experience was.
The main ﬁndings in our previous article describing the
clinical and epidemiological ﬁndings in these patients [18]
were that the introduction of crossed wire ﬁxation reduced
the median length of stay (LOS) from 11 to 2 days and that
there was no statistically signiﬁcant diﬀerence in complica-
tion rates between these two treatment groups. The large
reduction in LOS was intuitively an obvious improvement
for the children and their parents. There were also more
reoperations in the skeletal traction group (4/46) compared
to crossed wire ﬁxation (0/45, P = 0.04) because of unsatis-
factory reduction of the fracture. Given the nature of skeletal
traction treatment, the fact that the children needed to be
hospitalized more than ten days, and the need to undergo
generalanesthesiatwice,wehadexpectedtoﬁndthatcrossed
wire ﬁxation was less of a traumatic experience than skeletal
traction. However, this was not the case in this study. No
statistically signiﬁcant diﬀerences could be found in any of
the children’s VAS scores. In light of this one must ask one’s
self if a child’s rating of such an experience several years after
it happened can be trusted. There was a slight tendency for
the children’s VAS scores (mean 4.05) to be lower than their
caregivers’scores(mean4.5).Thiswouldsupportthegeneral
feeling that the children “forgive and forget” faster than
their parents. However, the diﬀerence was not statistically
signiﬁcant (P = 0.22) with the current study size and design.
Onecould,alongthesamelines,arguethattherelativelylong
followup was too long and that it would be expected that
the mean VAS score would decrease proportionately to the
number of years gone by since the fracture, but, as can be
seen from Table 1, this does not appear to be the case either.4 Advances in Orthopedics
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Figure 1: Parents’ rating of their experience of their child’s
SCHF on a visual analogue scale (VAS) according to if the child
experienced complications to the fracture or not. VAS 0 = “no
problem at all”, 10 = “a terrible experience.” Mean VAS ± 2 standard
error of the mean (SEM).
Time to followup in the wire ﬁxation and traction groups
was diﬀerent, and this diﬀerence in the children’s maturity,
or time gone by since the fracture, might be a source of bias.
The fact that the boys in this series rated their experience
less severe than the girls could, of course, be due to the boys’
not wanting to admit it was a bad experience as well as an
actual diﬀerence in their perception of the experience. Either
way it did display a gender diﬀerence we did not expect to
ﬁnd. It was also interesting to see that their parents did not
diﬀerentiate between the girls and the boys.
The present study has the usual limitations of being a re-
trospective study when it comes to collection of data about
the fractures and early complications. However, the info-
rmation on the children’s and their caregivers’ experience
of the treatment was prospectively collected as part of a
dedicatedstudyoutpatientvisit.Inouropinion, thefactthat
the patients were included consecutively before and after the
introduction of a new method, with as little separation in
time as possible, makes the groups comparable. One could
argue that there was a selection bias as only 111 children and
104 parents rated their experience of treatment for SCHF.
However, of the 181 patients identiﬁed from the hospital ﬁles
as having been treated for SCHF and invited to participate
in the study, 78% consented and returned for followup.
The relatively lower number of parents that responded can
be explained by the fact that not all the children came for
followup with their parents. Some of them came alone, with
older siblings, their grandparents, or another guardian. Also,
not all the children could or wanted to rate their experience.
All this considered, we do not think there is reason to
believe there has been a large selection bias. Power analysis
showed the sample size to be suﬃciently large to detect
clinically signiﬁcant diﬀerences, though smaller diﬀerences
could be overlooked. The statistically signiﬁcant diﬀerence
in VAS between parents with children who experienced
a neurovascular complication at some time during the
treatment and those that did not is hardly surprising.
However, in our opinion, the study has shown that the
parents’ VAS ratings were not completely random, even after
ﬁve to ten years. In eﬀect, it is likely that the ﬁndings that
there are no diﬀerences in their experience of the diﬀerent
treatment methods at long-term followup can be trusted.
Therewasnodiﬀerenceinthechildren’sorthecaregivers’
negative experience at long-term followup after treatment
for supracondylar humerus fractures as rated on a visual
analogue scale when comparing POP, skeletal traction, or
crossed wire ﬁxation. Caregivers to children that experienced
an e u r o v a s c u l a rc o m p l i c a t i o n ,h o w e v e r ,h a dam o r en e g a t i v e
experience independent of treatment or fracture type. In the
long term, then, whether or not complications could have
been avoided seems to be more important to the caregivers
than the choice of treatment for supracondylar humerus
fractures in the children. Though this might be of mostly
historical interest in high-income countries, in a limited
resource setting—where traction and casting often still is the
only treatment option for these injuries—surgeons may use
this information to inform parents and to prioritize the use
of resources in an orthopaedic department.
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